Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Squamous Cell Carcinoma of Head and Neck 7Prostatic Neoplasms 4Oropharyngeal Neoplasms 3Laryngeal Neoplasms 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Mouth Neoplasms 2Mesothelioma 2Hypopharyngeal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Carcinoma 2Astrocytoma 2Vaginal Neoplasms 1Urothelial Carcinoma of the Bladder 1Tongue Neoplasms 1Sarcoma 1Salivary Gland Neoplasms 1PSA Level Greater Than Two 1Oligodendroglioma 1Nasopharyngeal Carcinoma 1Mesothelioma, Malignant 1Lymphoma, Follicular 1Lymphoid Interstitial Pneumonia 1Lung Neoplasms 1Locally Advanced Cervical Adenocarcinoma 1Head and Neck Neoplasms 1Glioma 1Glioblastoma 1Extensive Stage Small Cell Lung Carcinoma 1Carcinoma, Squamous Cell 1

Interventions

Temozolomide 1Radiotherapy, Intensity-Modulated 1Mycophenolic Acid 1Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Glioblastoma × Radiotherapy, Intensity-Modulated × 30 days × Clear all
NCT07605364 2026-05-26

Testing the Addition of an Anti-Cancer Drug, Mycophenolate Mofetil, to the Usual Treatment (Radiation Therapy and Temozolomide) for Advanced Brain Cancer

Alliance for Clinical Trials in Oncology

Phase 2/3 Not yet recruiting
422 enrolled
CNS

Advanced Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡